Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Apnimed
Entity

Apnimed

Tracked across 2 events · 17 articles · First seen May 18, 2026 · Last active Aug 03, 2026

Sentiment
78
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
2 80
Business
Apnimed IPO on Nasdaq
Impact: Apnimed is the issuer of the IPO, raising $220.8 million in gross proceeds. The successful offering provides capital to advance its lead candidate AD109 and supports its transition to a publicly traded company.
Jul 31, 2026 · 10 articles
6 75
Tech
AD109 pill shows promise for Obstructive_sleep_apnea
Impact: Apnimed>>> is the company developing AD 109>>> and has submitted a New Drug Application to the United States — Food and Drug Administration>>>.
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Apnimed live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.